Sound Income Strategies’s 10x Genomics TXG Stock Holding History

Sound Income Strategies’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-629	Closed	-$13.9K	–	2254
2026 Q1	$13.9K	Buy	629 +140	+29%	+$2.8K	﹤0.01%	1351
2025 Q4	$10K	Buy	+489	New	+$7.39K	﹤0.01%	1466
2025 Q2	–	Sell	-4,110	Closed	-$35.9K	–	1709
2025 Q1	$35.9K	Buy	4,110 +740	+22%	+$9.33K	﹤0.01%	582
2024 Q4	$48.4K	Buy	3,370 +1,330	+65%	+$21K	﹤0.01%	471
2024 Q3	$46.1K	Buy	+2,040	New	+$42.2K	﹤0.01%	459

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sound Income Strategies's TXG Position: Q2 2026 in Review

Sound Income Strategies sold out of 10x Genomics (TXG) in Q2 2026, closing a stake of 629 shares — an estimated $13.9K sold.

Sound Income Strategies first reported a position in TXG in Q3 2024 and held it in 5 quarters. The position peaked at $48.4K in Q4 2024. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Sound Income Strategies reported no remaining 10x Genomics position as of Q2 2026 after selling out during the quarter.
Sound Income Strategies sold 629 10x Genomics shares in Q2 2026, an estimated $13.9K.
Sound Income Strategies first reported a position in 10x Genomics in Q3 2024 and held it in 5 quarters.
Sound Income Strategies's 10x Genomics position peaked at $48.4K in Q4 2024.
390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.